Seeking Alpha

Ligand Pharma beats by $0.06, beats on revenue

  • Ligand Pharma (LGND): FQ2 EPS of $0.12 beats by $0.06.
  • Revenue of $13M (+104% Y/Y) beats by $2.19M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector